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I have read the excellent paper by Ghanemi.1
The Author affirms that natural active compounds such as
flavonoids can be very helpful and have been described by
some others as natural medicine which is preventive rather
than curative.1
There is a problem when flavonoid or others benefical sub-
stances are in beverages as wine.
In fact, for the presence of flavonoid, moderate wine intake
is considered usefull for cardio-vascular (CV) prevention.2
This is a partial and dangerous scientific information.
In fact, in a glass of wine (125 ml, 12) 12 g of ethanol are
present.3
It is well known that ethanol is toxic. Therefore, ethanol in
wine is a toxic molecule.
It is also known that doses of below 2 drinks (<20–24 g of
ethanol)/day increase the risk of mortality and 1–2 drinks/day
increase the risk of atrial fibrillation, hypertension4,5 and
dilated cardiomyopathy.6
In addition, the World Health Organization (WHO) has
included alcoholic beverages, ethanol and acetaldehyde in
Group 1 IARC (International Agency for Research on Cancer
– WHO) and it is now known that there is no safe threshold
level.7 In Group 1 IARC there are substances that have a cau-
sal relationship with human cancer.
Approximately 10 g/day of ethanol increases the risk of
cancers of the oral cavity, pharynx, larynx, esophagus and
breast.5,8
Moreover, Whitman et al.4 recently showed that ‘‘individu-
als who recognize that moderate consumption has a protective
effect consume on average 50% more than those who do not
recognize this property of alcohol”.
For this reason it is appropriate to be prudent and to pro-
vide the correct information without satisfying the patients’
desire to maintain the pleasure of moderate consumption.
The choice to consume alcohol must be made freely, but with
an awareness of the risks involved. In addition, the health
report on alcohol and health should have a clear and unam-
biguous position: ethanol is toxic and carcinogenic.9Moreover, Lachenmeier et al.10 have demonstrated that
alcoholic beverages are multicomponent mixtures containing
several carcinogenic compounds. These are known and
suspected human carcinogens: ethanol, acetaldehyde,
acrylamide, aflatoxins, arsenic, benzene, cadmium, ethyl
carbamate, formaldehyde, furan, lead, 4-methylimidazole,
N-nitrosodimethylamine, ochratoxin A and safrole.
Thus, the alcohol production lobby should not be given the
opportunity to associate alcohol with health. It is unethical to
associate a carcinogen with health.
Moreover, it should be noted that the current data on alco-
hol and CV diseases is only correlative, whereas the toxic and
carcinogenic effects of ethanol and acetaldehyde have been
widely demonstrated and experimentally reproduced.11,12
Ethanol is not a nutrient, but a substance of nutritional
interest as it provides 7 kilocalories per gram. The low risk
ethanol dosage is 10 g/day for women and 20 g/day for men.13
The only tentative information that we can honestly give
our patients is that a cost-benefit assessment has indicated that
there are no safe thresholds with regard to the relationship
between alcohol and cancer.
We are, therefore, in agreement with the European Code
against Cancer, which states: ‘‘if you drink alcohol of any type,
limit your intake. Not drinking alcohol is better for cancer
prevention”.14
According to Ghanemi1 active elements found within food
or beverages may be toxic even taken at a small dosage: there-
fore, CV disease prevention cannot justify the use of alcoholic
beverages.
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